Inquiry
Form loading...
Explore our pharmaceutical-grade pure azelaic acid and complementary anti-inflammatory bioactive compounds for skin, health, and industrial applications.
Pure Azelaic Acid (nonanedioic acid, C₉H₁₆O₄) is a naturally occurring dicarboxylic acid found in wheat, rye, and barley, and produced endogenously by Malassezia species on human skin. In its pharmaceutical-grade form, it is a white to off-white crystalline powder with a minimum purity of 99%, recognized by the FDA, EMA, and international pharmacopoeias as a safe and highly effective active pharmaceutical ingredient (API).
Its multifaceted mechanism of action encompasses potent anti-inflammatory, antibacterial, antioxidant, and skin-brightening properties, making it one of the most scientifically validated bioactive compounds in modern dermatology, cosmeceuticals, and emerging industrial biotechnology sectors.
Inhibits reactive oxygen species (ROS) and suppresses pro-inflammatory cytokines including IL-1β, TNF-α, and IL-6 at the cellular level.
Derived from natural grain fermentation processes, achievable at ≥99% pharmaceutical purity under GMP-certified manufacturing conditions.
Simultaneously addresses inflammation, hyperpigmentation, bacterial colonization, and oxidative stress — a true multi-target active ingredient.
The anti-inflammatory efficacy of pure azelaic acid operates through several well-documented biochemical pathways. At the molecular level, it competitively inhibits the enzyme 5α-reductase, which reduces androgenic stimulation of sebaceous glands and decreases inflammatory mediator production. More critically, it suppresses the neutrophil-generated reactive oxygen species that perpetuate the inflammatory cascade in conditions such as acne vulgaris, rosacea, and post-inflammatory hyperpigmentation.
Recent in-vitro studies published in the Journal of Investigative Dermatology confirm that azelaic acid at concentrations of 15–20% significantly downregulates the NF-κB signaling pathway — the master regulator of inflammatory gene expression — providing a mechanistic explanation for its clinical efficacy that rivals many prescription-only anti-inflammatory agents.
Furthermore, pure azelaic acid demonstrates selective cytotoxicity toward abnormally proliferating melanocytes while sparing normal cells, a property that simultaneously addresses inflammation-driven pigmentation disorders without the systemic risks associated with hydroquinone or corticosteroids.
The global azelaic acid market is experiencing robust growth driven by surging demand across pharmaceutical, cosmeceutical, and industrial sectors.
The global pure azelaic acid market has transitioned from a niche dermatological API to a strategically important ingredient across multiple high-value industries. The pharmaceutical segment, led by branded topical formulations for acne and rosacea, continues to dominate market share, with Finacea® (15% azelaic acid gel) and Skinoren® (20% azelaic acid cream) maintaining strong prescription market positions in North America and Europe.
The cosmeceutical and over-the-counter (OTC) skincare segment is growing at an accelerated pace, fueled by the global "clean beauty" movement, increased consumer awareness of ingredient science, and the rising prevalence of sensitive skin conditions. Major DTC (direct-to-consumer) skincare brands — including The Ordinary, Paula's Choice, and Naturium — have integrated azelaic acid as a hero ingredient in their anti-inflammation and hyperpigmentation product lines, significantly expanding consumer market penetration.
| Application Sector | Key Use Cases | Concentration Range | Market Growth |
|---|---|---|---|
| Pharmaceutical (Rx) | Acne vulgaris, rosacea treatment | 15% – 20% | Stable / Mature |
| Cosmeceuticals (OTC) | Anti-inflammation serum, brightening cream | 5% – 15% | ⬆ High Growth |
| Nutraceuticals | Oral anti-inflammatory supplements | Low-dose oral | ⬆ Emerging |
| Industrial / Polymer | Plasticizers, lubricants, biopolymers | Industrial grade | Steady Growth |
| Agricultural Chemistry | Plant disease resistance enhancement | Research stage | ⬆ Early Stage |
The industry is witnessing several transformative trends that will shape the next decade of pure azelaic acid commercialization. Biotechnological fermentation-based production is replacing traditional petrochemical synthesis routes, yielding higher-purity products with significantly reduced environmental footprints — a critical differentiator for ESG-conscious global buyers.
Advanced nano-encapsulation and liposomal delivery technologies are being actively developed to overcome azelaic acid's inherent skin penetration limitations. Clinical trials using nanoparticle-encapsulated azelaic acid demonstrate up to 3× greater dermal bioavailability compared to conventional cream formulations, opening new therapeutic windows for deeper inflammatory conditions including seborrheic dermatitis and perioral dermatitis.
The convergence of microbiome science and azelaic acid research is another frontier. Emerging studies indicate that azelaic acid modulates the skin microbiome by selectively inhibiting pathogenic Cutibacterium acnes strains while preserving commensal bacterial populations — a property that aligns perfectly with the microbiome-friendly skincare trend commanding premium price points in the global market.
From clinical dermatology to industrial biopolymers, pure azelaic acid's anti-inflammatory and chemical properties unlock value across diverse sectors.
FDA-approved for papulopustular rosacea and acne vulgaris, pure azelaic acid at 15–20% concentration delivers clinically significant reduction in inflammatory lesion counts. Its dual mechanism — anti-inflammatory and antikeratinizing — makes it uniquely effective for patients intolerant to retinoids or antibiotics, with an excellent safety profile for use during pregnancy (Category B).
At 5–12% concentrations, pure azelaic acid functions as a multi-benefit cosmeceutical active: reducing erythema and flushing in sensitive skin, evening skin tone by inhibiting tyrosinase enzyme activity, and providing antioxidant protection against UV-induced inflammatory responses. It is increasingly formulated in combination with niacinamide, tranexamic acid, and retinol for synergistic anti-aging and anti-inflammation efficacy.
Emerging research explores low-dose oral azelaic acid for systemic anti-inflammatory benefits, particularly in metabolic syndrome and mild inflammatory conditions. Its natural grain origin positions it favorably within the nutraceutical regulatory frameworks of the EU and North America, where consumer demand for evidence-based natural anti-inflammatories is growing rapidly.
Beyond biomedical applications, azelaic acid serves as a key monomer in the production of polyamides, polyesters, and plasticizers. Its dicarboxylic acid structure enables synthesis of biodegradable polymers with superior flexibility characteristics. The industrial segment accounts for approximately 35% of global azelaic acid consumption, with demand driven by sustainable chemistry initiatives in the automotive, packaging, and textile industries.
Azelaic acid functions as a systemic acquired resistance (SAR) primer in plants, activating defense gene expression to enhance resistance against fungal and bacterial pathogens. Research published in Nature Chemical Biology identified azelaic acid as an endogenous mobile signal that primes distant plant tissues for pathogen defense — a discovery with significant implications for sustainable crop protection chemistry.
Next-generation therapeutic platforms are leveraging azelaic acid's selective antimicrobial properties to develop precision microbiome-modulating formulations. These applications target dysbiotic skin conditions — including seborrheic dermatitis, perioral dermatitis, and folliculitis — where restoring microbial balance alongside reducing inflammation represents a more holistic therapeutic approach than conventional antibiotic treatments.
Shaanxi Qiyuan Kangjian Biotechnology Co., Ltd. — Your trusted GMP-certified supplier of pure azelaic acid and bioactive ingredients.
Shaanxi Qiyuan Kangjian Biotechnology Co., Ltd. is located in Xi'an, Shaanxi Province, China, and specializes in supplying peptides, food additives, nutritional supplements, traditional Chinese medicine (TCM) extracts, plant extracts, and natural active ingredients.
Adhering to the corporate philosophy of "rooted in our initial vision, empowered by biotechnology; upholding integrity and taking steady action to benefit the people" and the belief that "quality is our lifeline," the company leverages its group operating model and global distribution network to serve clients in the pharmaceutical, health product, and cosmetics industries.
Qiyuan Kangjian Biotech Co., Ltd.
Our team members are familiar with the trade policies and compliance requirements of various countries, always prioritizing customer needs, strictly controlling quality, and responding efficiently. From order negotiation to after-sales follow-up, dedicated personnel handle the entire process, using professionalism and integrity to build bridges for cross-border cooperation and help partners explore global business opportunities!
Contact UsThe company has two major production bases in Weinan and Xianyang. Weinan Shenhekang Bioengineering Co., Ltd., established in 2022, boasts a 6,000-square-meter GMP-compliant production workshop.
This base is equipped with multi-functional plant extraction equipment for extraction, separation, concentration, and drying, as well as a complete production line, with an annual processing capacity of nearly 3,000 tons of various traditional Chinese medicinal materials and the production of 300 tons of raw materials.
The company has an independent R&D team and a standardized laboratory equipped with advanced testing instruments, including thin-layer chromatography (TLC), high-performance liquid chromatography (HPLC), ultraviolet-visible spectrophotometer (UV), and gas chromatography (GC), implementing strict technical control over the entire production process from raw material collection to finished product delivery.
The company has also established in-depth strategic partnerships with internationally renowned third-party testing organizations such as SGS, Eurofins, Layan Testing, and Pony Testing to ensure rigorous product quality management.
Serving pharmaceutical, health product, and cosmetics industries across 36+ countries with professional, integrity-driven global supply chain solutions.
Adhering to the corporate philosophy of "rooted in our initial vision, empowered by biotechnology; upholding integrity and taking steady action to benefit the people" and the belief that "quality is our lifeline," the company leverages its group operating model and global distribution network to serve clients in the pharmaceutical, health product, and cosmetics industries.
Its products have gained global recognition and are exported to over 36 countries in Asia, the Middle East, Europe, North America, Latin America, and Africa. With independent import and export licenses, the company has established strong partnerships with international express companies and air and sea freight forwarders to provide timely and professional services. The company also offers OEM customization services and tailored solutions for clients with new product ideas but lacking laboratory equipment and human resources.
From raw material sourcing to final delivery, every step is engineered for quality, compliance, and your competitive advantage.
6,000㎡ GMP-compliant workshop with full traceability from raw material to finished product, meeting international pharmaceutical standards.
In-house HPLC, TLC, UV, and GC testing, plus third-party verification through SGS, Eurofins, and Pony Testing for every batch.
Expert trade team navigating FDA, REACH, COSMOS, and regional regulatory requirements across 36+ countries for seamless market entry.
Full OEM services including custom concentration, formulation development, and white-label packaging for brands at any stage of development.
Competitive minimum order quantities with air, sea, and express freight options ensuring timely delivery to any global destination.
From initial inquiry to post-delivery support, dedicated personnel manage every touchpoint with professionalism and responsive communication.
Complete your formulation with our full range of pharmaceutical-grade anti-inflammatory active ingredients and plant extracts.
